Raffaele Pellegrino, who graduated in Medicine and Surgery from the University of Campania Luigi Vanvitelli, is involved in clinical activities as a Gastroenterology and Digestive Endoscopy practitioner at the Department of Precision Medicine, University of Campania Luigi Vanvitelli. Additionally, he is enrolled in a Ph.D. program in "Clinical and Experimental Medical Sciences" at the same university. He is a member of the Italian Society of Gastroenterology and Digestive Endoscopy (SIGE), European Crohn’s and Colitis Organisation, Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD), Italian Society of Digestive Endoscopy (SIED), and United European Gastroenterology. His research primarily focuses on the safety and efficacy of biologic drugs in IBD, the epidemiological stratification of patients with IBD for a tailored approach, translational studies to investigate new therapeutic targets for IBD, and gastrointestinal endoscopy.
Raffaele Pellegrino, who graduated in Medicine and Surgery from the University of Campania Luigi Vanvitelli, is involved in clinical activities as a Gastroenterology and Digestive Endoscopy practitioner at the Department of Precision Medicine, University of Campania Luigi Vanvitelli. Additionally, he is enrolled in a Ph.D. program in "Clinical and Experimental Medical Sciences" at the same university. He is a member of the Italian Society of Gastroenterology and Digestive Endoscopy (SIGE), European Crohn’s and Colitis Organisation, Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD), Italian Society of Digestive Endoscopy (SIED), and United European Gastroenterology. His research primarily focuses on the safety and efficacy of biologic drugs in IBD, the epidemiological stratification of patients with IBD for a tailored approach, translational studies to investigate new therapeutic targets for IBD, and gastrointestinal endoscopy.